Clinical Trials · NCT00938717
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Ironwood Pharmaceuticals, Inc.
- Enrollment
- 805
- Start date
- Jul 2009
- Locations
- 107 sites, United States
- Primary endpoint
- Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder, 9 Out of 12 Weeks